Triple

T21228240
Position Surface form Disambiguated ID Type / Status
Subject Conditional Marketing Authorization by European Medicines Agency E523137 entity
Predicate scientificAssessmentBy P70912 FINISHED
Object European Medicines Agency NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency | Statement: [Conditional Marketing Authorization by European Medicines Agency, scientificAssessmentBy, European Medicines Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: European Medicines Agency
Context triple: [Conditional Marketing Authorization by European Medicines Agency, scientificAssessmentBy, European Medicines Agency]
  • A. European Medicines Agency chosen
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • B. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • C. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • D. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: scientificAssessmentBy
Context triple: [Conditional Marketing Authorization by European Medicines Agency, scientificAssessmentBy, European Medicines Agency]
  • A. scientificAuthority chosen
    Indicates that one entity is recognized as an expert or authoritative source in scientific matters relative to another entity or context.
  • B. scientificTrackIncludes
    Indicates that a scientific track contains or encompasses a particular item, session, or component as part of its structure or content.
  • C. isScientific
    Indicates that something pertains to or is based on systematic scientific methods, principles, or knowledge.
  • D. scientificResearch
    Indicates that an entity conducts, participates in, or is the subject of systematic scientific investigation or study.
  • E. SCIType
    Indicates a classification relationship where an entity is assigned a specific type or category within a scientific or structured information context.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b512ad94819087942b2ed925185f completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e734ad5068819088b203eeba4e6380 completed April 21, 2026, 8:26 a.m.
PD Predicate disambiguation batch_69e5f60e1a888190ba75e2e900270a4e completed April 20, 2026, 9:46 a.m.
Created at: April 16, 2026, 3:44 p.m.